Enrotinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Enrotinib, covering 2023-09-21 to 2023-09-21. Get the full timeline:
Most recent: Clinical Trial Update: A Single Center, Single Arm Clinical Study on the Treatment of Advanced Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations and Failed EGFR TKIs With the Combination of Enrotinib and Paclitaxel Monoclonal Antibody [Phase 3]